Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorUniversity Hospital, Montpellier
About this trial
The aim of this cohort is to evaluate the follow-up of morbidly obese patients treated by several types of bariatric procedures. In addition, this study could lead to the development of clinical trials on assessment of the bariatric surgery impact.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Only be considered in patients operated and followed at CHU Montpellier with bariatric surgery
Patients treated by bariatric surgery on CHU Montpellier
Agreed to participate to the study by signing an informed consent
Eligible to health insurance
Disqualifiers
Unable to follow the patient in the long term (foreign patients, surgical use ...)
Inability to follow in the long run
Trial design
Design model
Single group
Treatments tested in this trial
Bariatric surgery
Procedure/Surgeryall of the current bariatric surgeries are allowed in this prospective cohort study
Treatment groups
750 Participants
are divided into 1 treatment groupGroup A: Group/CohortOther 1 intervention
Trial outcomes
Primary outcomes
1
Assessment of the long-term efficiency of bariatric surgery on weight loss
Assessment of weight loss
Time frame
Change from intervention to 5 yearsSecondary outcomes
1
Assessment of the long-term efficiency of bariatric surgery on diabetes
Assessment of blood glucose, HbA1c and diabetes medications
Time frame
Change from intervention to 5 years2
Assessment of the long-term efficiency of bariatric surgery on High Blood Pressure
Assessment of Systolic Blood Pressure and blood pressure medications
Time frame
Change from intervention to 5 years3
Assessment of the long-term efficiency of bariatric surgery on dyslipidemia
Assessment of cholesterolemia and triglyceridemia and dyslipidemia medications
Time frame
Change from intervention to 5 years4
Assessment of the long-term efficiency of bariatric surgery on rheumatism
Assessment of rheumatism medications
Time frame
Change from intervention to 5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov